This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Personalized nutrition is attracting attention from industry innovators, formulators and investors alike. Find out how supplement sales driven by personalized nutrition grew 35% to $375M in 2020.
The July 31 warning letter reflects FDA's continuing concern over the marketing of CBD products—including supplements—to treat diseases like cancer and schizophrenia without agency drug approval.
Pure or highly concentrated caffeine sold in powder and liquid forms is considered a safety issue and has been linked to two deaths. Warning letters in 2015 and 2016 labeled the sales unlawful, but the new guidance details the prohibition.
The supplement industry heads into the new year with forward momentum, but adequate funding for FDA's Office of Dietary Supplement Products is critical.